High-risk stays high-risk: Bruton tyrosine kinase inhibitors in B-cell malignancies. Al-Sawaf O. Haematologica 2024;109:2035-2037.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Al-Sawaf O. High-risk stays high-risk: Bruton tyrosine kinase inhibitors in B-cell malignancies. Haematologica 2024;109:2035-2037.
PMID: 38450529